Literature DB >> 30474588

Patient and Staff Engagement in Health System Improvement: A Qualitative Evaluation of the Experience-Based Co-design Approach in Canada.

Kate Bak1, Lesley Moody2, Sarah M Wheeler3, Julie Gilbert4.   

Abstract

Surveys and interviews were undertaken in Ontario, Canada, with healthcare staff, patients, caregivers and family members to evaluate the adoption and effectiveness of the experience-based co-design (EBCD) approach. EBCD combines patient and staff experiences to identify opportunities for healthcare improvement. Participants reported that EBCD was an effective form of improving experience. Implementation barriers included time, human resources and funding. Suggestions for increased EBCD utilization included funding, training, promotion of success stories, leadership and greater participant involvement. EBCD can be an effective method of identifying and transforming how healthcare services are delivered to improve the patient, caregiver and family experience.
Copyright © 2018 Longwoods Publishing.

Entities:  

Mesh:

Year:  2018        PMID: 30474588     DOI: 10.12927/hcq.2018.25626

Source DB:  PubMed          Journal:  Healthc Q        ISSN: 1710-2774


  3 in total

1.  Hospital capacity for patient engagement in planning and improving health services: a cross-sectional survey.

Authors:  Anna R Gagliardi; Juan Pablo Diaz Martinez; G Ross Baker; Lesley Moody; Kerseri Scane; Robin Urquhart; Walter P Wodchis
Journal:  BMC Health Serv Res       Date:  2021-02-25       Impact factor: 2.655

2.  Engagement of older adults in regional health innovation: The ECOTECH concept mapping project.

Authors:  Heather McNeil; Josephine McMurray; Kerry Byrne; Kelly Grindrod; Paul Stolee
Journal:  SAGE Open Med       Date:  2022-01-21

Review 3.  Co-produced capability framework for successful patient and staff partnerships in healthcare quality improvement: results of a scoping review.

Authors:  Ruth Cox; Matthew Molineux; Melissa Kendall; Bernadette Tanner; Elizabeth Miller
Journal:  BMJ Qual Saf       Date:  2021-07-12       Impact factor: 7.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.